Search

everythinglearnresearchcommunity

for

Search:↓

Erdr1 could be a new marker for diagnosing hair loss.

The document explains the genetic causes and characteristics of inherited hair disorders.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Researchers created human cells that can turn into sebocytes, which may help study and treat skin conditions like acne.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Finasteride helps female-pattern hair loss.

Cyclosporin doesn't stop hair loss.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

Apoptosis is crucial for healthy skin and treating skin diseases.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.